Related Experiment Video
Updated: Jan 28, 2026
07:21
Quantitative Microtubule Fractionation Technique to Separate Stable Microtubules, Labile Microtubules, and Free Tubulin in Mouse Tissues
Published on: November 17, 2023
2.7K
Microtubule-Targeting Drugs: More than Antimitotics
Journal of Natural Products
|March 6, 2019
Summary
Natural products targeting microtubules are vital cancer drugs. Beyond inhibiting cell division, they disrupt signaling pathways in non-dividing cancer cells, enhancing their effectiveness, especially in solid tumors.
Area of Science:
- Cell Biology
- Pharmacology
- Oncology
Background:
- Microtubules are crucial cellular components targeted by numerous natural products.
- Microtubule-targeting agents (MTAs) derived from natural products are effective in treating various cancers, including solid tumors and hematological malignancies.
- Historically, MTAs were believed to function solely by inhibiting mitosis.
Purpose of the Study:
- To review the multifaceted roles of microtubules in cellular functions.
- To explore the complex mechanisms of action of microtubule-targeting drugs beyond mitosis inhibition.
- To discuss the inhibition of oncogenic signaling pathways by MTAs in both dividing and non-dividing cancer cells.
Main Methods:
- Review of existing literature on microtubule function and MTA mechanisms.
- Analysis of evidence demonstrating MTA effects on cellular signaling pathways.
- Discussion of the proliferation paradox in cancer cells versus cells in culture.
Main Results:
- Microtubule-targeting drugs exhibit complex actions beyond mitotic arrest.
- MTAs significantly impact microtubule function in non-dividing cells, inhibiting critical signaling pathways involved in carcinogenesis.
- Inhibition of oncogenic signaling by MTAs is a key factor in their efficacy, particularly against solid tumors.
Conclusions:
- Microtubules represent a significant target for diverse natural product-derived anticancer agents.
- The efficacy of MTAs is attributed to their dual action: inhibiting mitosis and disrupting oncogenic signaling pathways.
- A comprehensive understanding of MTA mechanisms will optimize their clinical application in cancer therapy.
Related Concept Videos
01:10Drugs that Destabilize Microtubules
3.7K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.7K
01:15Drugs that Stabilize Microtubules
2.7K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.7K
01:35Microtubules
98.8K
There are three types of cytoskeletal structures in eukaryotic cells—microfilaments, intermediate filaments, and microtubules. With a diameter of about 25 nm, microtubules are the thickest of these fibers. Microtubules carry out a variety of functions that include cell structure and support, transport of organelles, cell motility (movement), and the separation of chromosomes during cell division.
98.8K
01:18Microtubules
10.6K
Microtubules are the thickest cytoskeletal filaments with a diameter of 25 nm. In prokaryotic organisms, microtubules are commonly found in locomotory appendages like cilia and flagella. In eukaryotic cells, microtubules form specialized extensions for moving fluid over the surface, like those found in cells lining the intestine.
Microtubules have two structurally similar globular protein subunits: α and β tubulins. In the cytosol, the α and β tubulins form a heterodimer....
Microtubules have two structurally similar globular protein subunits: α and β tubulins. In the cytosol, the α and β tubulins form a heterodimer....
10.6K
01:26Targets for Drug Action: Overview
10.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.2K
02:17Microtubule Instability
6.2K
Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
6.2K